0000769397-23-000169.txt : 20230901
0000769397-23-000169.hdr.sgml : 20230901
20230901205643
ACCESSION NUMBER: 0000769397-23-000169
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230901
FILED AS OF DATE: 20230901
DATE AS OF CHANGE: 20230901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anagnost Andrew
CENTRAL INDEX KEY: 0001661768
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14338
FILM NUMBER: 231233846
MAIL ADDRESS:
STREET 1: 111 MCINNIS PARKWAY
STREET 2: AUTODESK, INC.
CITY: SAN RAFAEL
STATE: CA
ZIP: 94903
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Autodesk, Inc.
CENTRAL INDEX KEY: 0000769397
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 942819853
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: ONE MARKET, STE. 400.
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 4155075000
MAIL ADDRESS:
STREET 1: ONE MARKET, STE. 400.
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: AUTODESK INC
DATE OF NAME CHANGE: 19920703
4
1
wk-form4_1693616194.xml
FORM 4
X0508
4
2023-09-01
0
0000769397
Autodesk, Inc.
ADSK
0001661768
Anagnost Andrew
ONE MARKET, SUITE 400
SAN FRANCISCO
CA
94105
1
1
0
0
President and CEO
1
Common Stock
2023-09-01
4
S
0
6745
221.15
D
114900
D
Common Stock
2023-09-01
4
S
0
12950
221.92
D
101950
D
Common Stock
2023-09-01
4
S
0
1008
223.24
D
100942
D
Common Stock
2023-09-01
4
S
0
1615
224.04
D
99327
D
The sales reported in this form were effected pursuant to a Rule 105b-1 trading plan adopted by the reporting person on 05/26/2023.
Shares were sold in various amounts from $220.54 to $221.51 inclusive. The price listed here reflects the average weighted price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The total securities beneficially owned includes 71,319 shares of unvested Restricted Stock Units.
Shares were sold in various amounts from $221.54 to $222.43 inclusive. The price listed here reflects the average weighted price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares were sold in various amounts from $222.54 to $223.53 inclusive. The price listed here reflects the average weighted price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares were sold in various amounts from $223.80 to $224.13 inclusive. The price listed here reflects the average weighted price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Melissa Hoge, Attorney-in-Fact for Andrew Anagnost
2023-09-01